Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation

Ki Nam Kim; Jae Eun Pie; Jin Hee Park; Yoon Hee Park; Hye Won Kim; Meyoung kon Kim

doi:10.1016/j.jnutbio.2005.10.009

Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation

Ki Nam Kim, Jae Eun Pie, Jin Hee Park, Yoon Hee Park, Hye Won Kim, Meyoung kon Kim

Research output: Contribution to journal › Article › peer-review

35 Citations (Scopus)

Abstract

Background: Breast cancer is an increasingly common malignancy. Several vitamins such as retinoic acid (RA), ascorbic acid (AA), vitamin D and vitamin E are known to prevent the development and progression of breast cancer. Objective: We sought to determine whether RA and AA together (RA+AA) acted synergistically in blocking the proliferation of human breast cancer cells. To elucidate the mechanism by which RA+AA inhibited breast carcinoma proliferation, we then evaluated the gene expression profiles of the treated and untreated cells by radioactive cDNA microarray analysis. Methods: We cultured the human breast cancer cell line MCF-7 for 3 days with 100 nM RA and/or 1 mM AA, counted the cell numbers and harvested the total RNAs for cDNA microarray analysis. Results: RA, AA and RA+AA reduced MCF-7 cell proliferation by 20.7%, 23.3% and 75.7% relative to the untreated cell proliferation, respectively. The synergistic ratio of RA and AA was 1.72. The MCF-7 gene expression profiles showed that 29 genes were up-regulated and 38 genes were down-regulated after RA+AA treatment. The nature of these genes suggests that the mechanism by which RA and AA act synergistically in inhibiting human breast cancer cell proliferation may involve the expression of genes that induce differentiation and block proliferation, and the up-regulation of antioxidant enzymes and proteins involved in apoptosis, cell cycle regulation and DNA repair. Conclusion: Combined treatment with RA and AA inhibits the proliferation of human breast cancer cells by altering their gene expression related to antioxidation processes as well as the proliferation inhibitory pathway.

Original language	English
Pages (from-to)	454-462
Number of pages	9
Journal	Journal of Nutritional Biochemistry
Volume	17
Issue number	7
DOIs	https://doi.org/10.1016/j.jnutbio.2005.10.009
Publication status	Published - 2006 Aug

Bibliographical note

Funding Information:
This study was financially supported by the Korea Science and Engineering Foundation (grant no. R01-2001-000-00212-0); was supported by a grant from the Medical Research Center for Environmental Toxicogenomic and Proteomics, funded by the Korea Science and Engineering Foundations and Ministry of Science and Technology; a grant from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (Hmp-00-GN-01-0002 & KPGRN-R-04); the Korea Institute of Science and Technology Evaluation and Planning and Ministry of Science and Technology, Korean government, through its National Nuclear Technology Program. We thank Dr. Yoon S. Cho-Chung (Cellular Biochemistry Section, Basic Research Laboratory, CCR, NCI, NIH, Bethesda, MD) and Kevin G. Becker (DNA Array Unit, NIA, NIH, Baltimore, MD) for valuable advice about the cDNA microarray analysis. In addition, we are grateful to Seung-Ho Lee, Yeon-Mi Rhyu, Sung-Hwa Sohn, Sang-Hee Seo and Yu-Ri Kim (Department of Biochemistry and Molecular Biology, Korea University Medical College, Seoul, Korea) for their technical assistance in this investigation.

Keywords

Anti-proliferation
Ascorbic acid
Combined treatment of vitamins
Human breast cancer
Retinoic acid
cDNA microarray

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Biochemistry
Molecular Biology
Nutrition and Dietetics
Clinical Biochemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jnutbio.2005.10.009

Cite this

@article{601ed37ffa114365866a97b2ae54f628,

title = "Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation",

abstract = "Background: Breast cancer is an increasingly common malignancy. Several vitamins such as retinoic acid (RA), ascorbic acid (AA), vitamin D and vitamin E are known to prevent the development and progression of breast cancer. Objective: We sought to determine whether RA and AA together (RA+AA) acted synergistically in blocking the proliferation of human breast cancer cells. To elucidate the mechanism by which RA+AA inhibited breast carcinoma proliferation, we then evaluated the gene expression profiles of the treated and untreated cells by radioactive cDNA microarray analysis. Methods: We cultured the human breast cancer cell line MCF-7 for 3 days with 100 nM RA and/or 1 mM AA, counted the cell numbers and harvested the total RNAs for cDNA microarray analysis. Results: RA, AA and RA+AA reduced MCF-7 cell proliferation by 20.7%, 23.3% and 75.7% relative to the untreated cell proliferation, respectively. The synergistic ratio of RA and AA was 1.72. The MCF-7 gene expression profiles showed that 29 genes were up-regulated and 38 genes were down-regulated after RA+AA treatment. The nature of these genes suggests that the mechanism by which RA and AA act synergistically in inhibiting human breast cancer cell proliferation may involve the expression of genes that induce differentiation and block proliferation, and the up-regulation of antioxidant enzymes and proteins involved in apoptosis, cell cycle regulation and DNA repair. Conclusion: Combined treatment with RA and AA inhibits the proliferation of human breast cancer cells by altering their gene expression related to antioxidation processes as well as the proliferation inhibitory pathway.",

keywords = "Anti-proliferation, Ascorbic acid, Combined treatment of vitamins, Human breast cancer, Retinoic acid, cDNA microarray",

author = "Kim, {Ki Nam} and Pie, {Jae Eun} and Park, {Jin Hee} and Park, {Yoon Hee} and Kim, {Hye Won} and Kim, {Meyoung kon}",

note = "Funding Information: This study was financially supported by the Korea Science and Engineering Foundation (grant no. R01-2001-000-00212-0); was supported by a grant from the Medical Research Center for Environmental Toxicogenomic and Proteomics, funded by the Korea Science and Engineering Foundations and Ministry of Science and Technology; a grant from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (Hmp-00-GN-01-0002 & KPGRN-R-04); the Korea Institute of Science and Technology Evaluation and Planning and Ministry of Science and Technology, Korean government, through its National Nuclear Technology Program. We thank Dr. Yoon S. Cho-Chung (Cellular Biochemistry Section, Basic Research Laboratory, CCR, NCI, NIH, Bethesda, MD) and Kevin G. Becker (DNA Array Unit, NIA, NIH, Baltimore, MD) for valuable advice about the cDNA microarray analysis. In addition, we are grateful to Seung-Ho Lee, Yeon-Mi Rhyu, Sung-Hwa Sohn, Sang-Hee Seo and Yu-Ri Kim (Department of Biochemistry and Molecular Biology, Korea University Medical College, Seoul, Korea) for their technical assistance in this investigation.",

year = "2006",

month = aug,

doi = "10.1016/j.jnutbio.2005.10.009",

language = "English",

volume = "17",

pages = "454--462",

journal = "Journal of Nutritional Biochemistry",

issn = "0955-2863",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation

AU - Kim, Ki Nam

AU - Pie, Jae Eun

AU - Park, Jin Hee

AU - Park, Yoon Hee

AU - Kim, Hye Won

AU - Kim, Meyoung kon

N1 - Funding Information: This study was financially supported by the Korea Science and Engineering Foundation (grant no. R01-2001-000-00212-0); was supported by a grant from the Medical Research Center for Environmental Toxicogenomic and Proteomics, funded by the Korea Science and Engineering Foundations and Ministry of Science and Technology; a grant from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (Hmp-00-GN-01-0002 & KPGRN-R-04); the Korea Institute of Science and Technology Evaluation and Planning and Ministry of Science and Technology, Korean government, through its National Nuclear Technology Program. We thank Dr. Yoon S. Cho-Chung (Cellular Biochemistry Section, Basic Research Laboratory, CCR, NCI, NIH, Bethesda, MD) and Kevin G. Becker (DNA Array Unit, NIA, NIH, Baltimore, MD) for valuable advice about the cDNA microarray analysis. In addition, we are grateful to Seung-Ho Lee, Yeon-Mi Rhyu, Sung-Hwa Sohn, Sang-Hee Seo and Yu-Ri Kim (Department of Biochemistry and Molecular Biology, Korea University Medical College, Seoul, Korea) for their technical assistance in this investigation.

PY - 2006/8

Y1 - 2006/8

N2 - Background: Breast cancer is an increasingly common malignancy. Several vitamins such as retinoic acid (RA), ascorbic acid (AA), vitamin D and vitamin E are known to prevent the development and progression of breast cancer. Objective: We sought to determine whether RA and AA together (RA+AA) acted synergistically in blocking the proliferation of human breast cancer cells. To elucidate the mechanism by which RA+AA inhibited breast carcinoma proliferation, we then evaluated the gene expression profiles of the treated and untreated cells by radioactive cDNA microarray analysis. Methods: We cultured the human breast cancer cell line MCF-7 for 3 days with 100 nM RA and/or 1 mM AA, counted the cell numbers and harvested the total RNAs for cDNA microarray analysis. Results: RA, AA and RA+AA reduced MCF-7 cell proliferation by 20.7%, 23.3% and 75.7% relative to the untreated cell proliferation, respectively. The synergistic ratio of RA and AA was 1.72. The MCF-7 gene expression profiles showed that 29 genes were up-regulated and 38 genes were down-regulated after RA+AA treatment. The nature of these genes suggests that the mechanism by which RA and AA act synergistically in inhibiting human breast cancer cell proliferation may involve the expression of genes that induce differentiation and block proliferation, and the up-regulation of antioxidant enzymes and proteins involved in apoptosis, cell cycle regulation and DNA repair. Conclusion: Combined treatment with RA and AA inhibits the proliferation of human breast cancer cells by altering their gene expression related to antioxidation processes as well as the proliferation inhibitory pathway.

AB - Background: Breast cancer is an increasingly common malignancy. Several vitamins such as retinoic acid (RA), ascorbic acid (AA), vitamin D and vitamin E are known to prevent the development and progression of breast cancer. Objective: We sought to determine whether RA and AA together (RA+AA) acted synergistically in blocking the proliferation of human breast cancer cells. To elucidate the mechanism by which RA+AA inhibited breast carcinoma proliferation, we then evaluated the gene expression profiles of the treated and untreated cells by radioactive cDNA microarray analysis. Methods: We cultured the human breast cancer cell line MCF-7 for 3 days with 100 nM RA and/or 1 mM AA, counted the cell numbers and harvested the total RNAs for cDNA microarray analysis. Results: RA, AA and RA+AA reduced MCF-7 cell proliferation by 20.7%, 23.3% and 75.7% relative to the untreated cell proliferation, respectively. The synergistic ratio of RA and AA was 1.72. The MCF-7 gene expression profiles showed that 29 genes were up-regulated and 38 genes were down-regulated after RA+AA treatment. The nature of these genes suggests that the mechanism by which RA and AA act synergistically in inhibiting human breast cancer cell proliferation may involve the expression of genes that induce differentiation and block proliferation, and the up-regulation of antioxidant enzymes and proteins involved in apoptosis, cell cycle regulation and DNA repair. Conclusion: Combined treatment with RA and AA inhibits the proliferation of human breast cancer cells by altering their gene expression related to antioxidation processes as well as the proliferation inhibitory pathway.

KW - Anti-proliferation

KW - Ascorbic acid

KW - Combined treatment of vitamins

KW - Human breast cancer

KW - Retinoic acid

KW - cDNA microarray

UR - http://www.scopus.com/inward/record.url?scp=33744972823&partnerID=8YFLogxK

U2 - 10.1016/j.jnutbio.2005.10.009

DO - 10.1016/j.jnutbio.2005.10.009

M3 - Article

C2 - 16443354

AN - SCOPUS:33744972823

SN - 0955-2863

VL - 17

SP - 454

EP - 462

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

IS - 7

ER -

Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this